Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLYCD | O95822 | 1/20 | 0.34 |
| ▸ | GRIN2B | Q13224 | 4/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.32 |
| ▸ | POLQ | O75417 | 3/20 | 0.31 |
| ▸ | GFER | P55789 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20636705 | 0.83 | KMT2A (0.37) | GRIN2BPTGDR2GFERHTTSLC2A1 | |
| SCHEMBL20636708 | 0.83 | POLB (0.37) | PTGDR2GFERHTTSLC2A1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL20636716 | 0.82 | POLB (0.37) | PTGDR2GFERHTTSLC2A1ALDH1A1 | |
| SCHEMBL20636714 | 0.82 | HTT (0.36) | GRIN2BPTGDR2GFERHTTSLC2A1 | |
| SCHEMBL20636702 | 0.82 | MAPT (0.39) | ALDH1A1 | |
| SCHEMBL19711983 | 0.75 | USP7 (0.35) | MLYCDGRIN2BPTGDR2GFERALDH1A1 | |
| SCHEMBL18908841 | 0.70 | ALDH1A1 (0.41) | MLYCDPOLQALDH1A1 | |
| SCHEMBL21307805 | 0.68 | CFTR (0.42) | ALDH1A1 | |
| SCHEMBL20636695 | 0.68 | PDE10A (0.37) | — | |
| SCHEMBL20636720 | 0.67 | MAPT (0.41) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10759815-B2 | Condensed heterocyclic compounds and pesticides | NISSAN CHEMICAL CORPORATION (JP) | 2020-09-01 | — | — | US | disclosed |
| US-20200223868-A1 | CONDENSED HETEROCLYCLIC COMPOUNDS AND PESTICIDES | NISSAN CHEMICAL CORPORATION (JP) | 2020-07-16 | — | — | US | disclosed |
| US-10640518-B2 | Condensed heterocyclic compounds and pesticides | NISSAN CHEMICAL CORPORATION (JP) | 2020-05-05 | — | — | US | disclosed |
| US-20200095263-A1 | CONDENSED HETEROCYCLIC COMPOUNDS AND PESTICIDES | NISSAN CHEMICAL CORPORATION (JP) | 2020-03-26 | — | — | US | disclosed |
| US-10544163-B2 | Condensed heterocyclic compounds and pesticides | NISSAN CHEMICAL CORPORATION (JP) | 2020-01-28 | — | — | US | disclosed |
| EP-3428166-A1 | CONDENSED HETEROCYCLIC COMPOUND AND PEST CONTROL AGENT | Nissan Chemical Corporation (JP) | 2019-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10759815-B2 | Condensed heterocyclic compounds and pesticides | NR4A1, CHRM1, NR1D2 | MLYCD 2828/4885GRIN2B 221/4885PTGDR2 1731/4885 |
| US-20200223868-A1 | CONDENSED HETEROCLYCLIC COMPOUNDS AND PESTICIDES | CHRM1, HCRTR1, NR4A1 | MLYCD 2970/4885GRIN2B 503/4885PTGDR2 2183/4885 |
| US-10544163-B2 | Condensed heterocyclic compounds and pesticides | NR4A1, CHRM1, NR1D2 | MLYCD 2814/4885GRIN2B 244/4885PTGDR2 1656/4885 |
| US-20200095263-A1 | CONDENSED HETEROCYCLIC COMPOUNDS AND PESTICIDES | NR4A1, CHRM1, NR1D2 | MLYCD 2814/4885GRIN2B 244/4885PTGDR2 1656/4885 |
| US-10640518-B2 | Condensed heterocyclic compounds and pesticides | NR4A1, CHRM1, NR1D2 | MLYCD 2777/4885GRIN2B 213/4885PTGDR2 1701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.